| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] MLL started as importer/trader of critical and specialized pesticide formulations has now started manufacturing the same. The company posted growth in its top and bottom lines for the reported periods. Boosted top and bottom lines from FY25 onwards raise eyebrows and concern over its sustainability. Based on its recent financial data, the issue appears fully priced. Investors may park funds for medium to long term. Read detail review...
Mahamaya Lifesciences Ltd. peer comparison with similar listed entities. (As on March 31, 2025)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Mahamaya Lifesciences Limited | 7.60 | 7.60 | 27.82 | 26.19 | Consolidated | ||
| Nova Agritech Limited | 3.05 | 3.05 | 23.76 | 16.93 | 12.47 | 2.22 | Consolidated |
| Bhagiradha Chemicals & Industries Ltd. | 1.14 | 1.14 | 52.61 | 247.63 | 2.03 | 5.42 | Consolidated |
Notes:
Mahamaya Lifesciences IPO Reviews, analysis and views by popular members. Read Mahamaya Lifesciences Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Post Recommendation Manage Recommendations
Note:
Useful Articles
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
RHP
